Genomic Valley Biotech to review quarterly results at August 14 board meeting Back

Genomic Valley Biotech Limited will hold a meeting of its Board of Directors on August 14, 2026, to consider and approve the unaudited financial results (standalone) for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The company has also closed the trading window for directors, key managerial personnel, promoters, and designated persons from July 1, 2026, until 48 hours after the results are made public on August 14, 2026.